Healthcare provider profile · identity verified

Jefferson A Schott, MD

Internal Medicine · HIGHLAND PARK, IL · NPI 1811927221

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	785	221
Levothyroxine Sodium	Levothyroxine Sodium	577	151
Rosuvastatin Calcium	Rosuvastatin Calcium	437	132
Amlodipine Besylate	Amlodipine Besylate	390	110
Lisinopril	Lisinopril	259	71
Simvastatin	Simvastatin	242	71
Hydrochlorothiazide	Hydrochlorothiazide	224	67
Metformin Hcl Er	Metformin Hcl	221	51
Omeprazole	Omeprazole	207	67
Alprazolam	Alprazolam	206	51
Escitalopram Oxalate	Escitalopram Oxalate	184	59
Losartan Potassium	Losartan Potassium	183	57
Zolpidem Tartrate	Zolpidem Tartrate	177	44
Pantoprazole Sodium	Pantoprazole Sodium	172	55
Tamsulosin Hcl	Tamsulosin Hcl	159	55
Metoprolol Succinate	Metoprolol Succinate	158	49
Gabapentin	Gabapentin	154	43
Trazodone Hcl	Trazodone Hcl	154	51
Glimepiride	Glimepiride	146	33
Irbesartan	Irbesartan	119	34
Ozempic	Semaglutide	108	24
Ezetimibe	Ezetimibe	101	35
Metformin Hcl	Metformin Hcl	94	31
Pravastatin Sodium	Pravastatin Sodium	93	30
Allopurinol	Allopurinol	90	30
Ramipril	Ramipril	88	25
Eliquis	Apixaban	80	17
Januvia	Sitagliptin Phosphate	78	13
Finasteride	Finasteride	69	22
Metoprolol Tartrate	Metoprolol Tartrate	68	20
Sertraline Hcl	Sertraline Hcl	66	24
Duloxetine Hcl	Duloxetine Hcl	63	20
Furosemide	Furosemide	61	23
Terazosin Hcl	Terazosin Hcl	60	18
Lorazepam	Lorazepam	57	19
Mirtazapine	Mirtazapine	57	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	56	14
Fluticasone Propionate	Fluticasone Propionate	52	19
Diazepam	Diazepam	50	suppressed
Farxiga	Dapagliflozin Propanediol	50	suppressed
Montelukast Sodium	Montelukast Sodium	48	15
Albuterol Sulfate Hfa	Albuterol Sulfate	46	21
Clonazepam	Clonazepam	46	17
Enalapril Maleate	Enalapril Maleate	46	14
Potassium Chloride	Potassium Chloride	44	14
Bupropion Xl	Bupropion Hcl	43	13
Olmesartan Medoxomil	Olmesartan Medoxomil	43	11
Alendronate Sodium	Alendronate Sodium	42	suppressed
Synthroid	Levothyroxine Sodium	42	13
Carvedilol	Carvedilol	38	15
Clopidogrel	Clopidogrel Bisulfate	38	11
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	38	suppressed
Meloxicam	Meloxicam	38	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	suppressed
Famotidine	Famotidine	36	12
Mounjaro	Tirzepatide	36	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	34	11
Temazepam	Temazepam	34	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Valsartan	Valsartan	33	11
Celecoxib	Celecoxib	32	12
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	11
Warfarin Sodium	Warfarin Sodium	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Topiramate	Topiramate	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	14
Tramadol Hcl	Tramadol Hcl	28	13
Candesartan Cilexetil	Candesartan Cilexetil	27	suppressed
Eszopiclone	Eszopiclone	27	suppressed
Olanzapine	Olanzapine	27	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	suppressed
Prednisone	Prednisone	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Azelastine Hcl	Azelastine Hcl	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	19
Azithromycin	Azithromycin	22	17
Zaleplon	Zaleplon	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Atenolol	Atenolol	19	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Propranolol Hcl	Propranolol Hcl	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Sildenafil Citrate	Sildenafil Citrate	18	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Methylprednisolone	Methylprednisolone	17	16
Myrbetriq	Mirabegron	17	suppressed
Repaglinide	Repaglinide	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	14
Benazepril Hcl	Benazepril Hcl	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Testosterone	Testosterone	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Tadalafil	Tadalafil	12	suppressed
Zenpep	Lipase/Protease/Amylase	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Baclofen	Baclofen	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error